BAT to Launch Synthetic Nicotine e-Cigarette in South Korea

Sep.23.2024
BAT to Launch Synthetic Nicotine e-Cigarette in South Korea
BAT plans to release a synthetic nicotine e-cigarette named "Nomad" in South Korea, taking advantage of legal loopholes there.

According to N.News on September 23rd, British American Tobacco (BAT) announced that they will be releasing a synthetic nicotine e-cigarette in November.


British American Tobacco's South Korean subsidiary revealed on the 23rd that its synthetic nicotine e-cigarette, named "Nomad", has applied for a trademark and is scheduled to be officially launched in November.


BAT hinted as early as May of this year that it was planning to launch this new product. Currently, South Korea will be the only country in the world to sell this synthetic nicotine e-cigarette.


Industry insiders believe that BAT is interested in South Korea due to the lack of clear legal regulations on synthetic nicotine e-cigarettes in the country. According to current tobacco laws in South Korea, only products made from tobacco leaves are recognized, so synthetic nicotine e-cigarettes are not considered traditional tobacco products. This allows them to be sold online and to minors without restrictions.


In addition, these synthetic nicotine e-cigarettes are not subject to taxation, which means their prices may be lower than regular tobacco and traditional e-cigarettes.


According to reports, discussions regarding legal amendments in South Korea have been stalled. During the 21st National Assembly session, four bills aimed at expanding the definition of tobacco to include synthetic nicotine products were proposed, but were ultimately scrapped as the parliamentary term came to an end. In the 22nd National Assembly, there are currently five related bills proposed.


We welcome news tips, article submissions, interview requests, or comments on this piece.

Please contact us at info@2firsts.com, or reach out to Alan Zhao, CEO of 2Firsts, on LinkedIn


Notice

1.  This article is intended solely for professional research purposes related to industry, technology, and policy. Any references to brands or products are made purely for objective description and do not constitute any form of endorsement, recommendation, or promotion by 2Firsts.

2.  The use of nicotine-containing products — including, but not limited to, cigarettes, e-cigarettes, nicotine pouchand heated tobacco products — carries significant health risks. Users are responsible for complying with all applicable laws and regulations in their respective jurisdictions.

3.  This article is not intended to serve as the basis for any investment decisions or financial advice. 2Firsts assumes no direct or indirect liability for any inaccuracies or errors in the content.

4.  Access to this article is strictly prohibited for individuals below the legal age in their jurisdiction.

 

Copyright

 

This article is either an original work created by 2Firsts or a reproduction from third-party sources with proper attribution. All copyrights and usage rights belong to 2Firsts or the original content provider. Unauthorized reproduction, distribution, or any other form of unauthorized use by any individual or organization is strictly prohibited. Violators will be held legally accountable.

For copyright-related inquiries, please contact: info@2firsts.com

 

AI Assistance Disclaimer

 

This article may have been enhanced using AI tools to improve translation and editorial efficiency. However, due to technical limitations, inaccuracies may occur. Readers are encouraged to refer to the cited sources for the most accurate information.

We welcome any corrections or feedback. Please contact us at: info@2firsts.com

BPOM Indonesia: Crackdown on Ketamine-Laced Vape Products
BPOM Indonesia: Crackdown on Ketamine-Laced Vape Products
Indonesia’s Food and Drug Monitoring Agency (BPOM) announced it will take strict enforcement action against vape products found to contain ketamine. BPOM Chief Taruna Ikrar emphasized that the agency’s focus is not whether the product is a cigarette or a vape, but whether it contains harmful substances. Recently, the National Narcotics Agency (BNN) has seized multiple cases of ketamine and other new psychoactive substances allegedly intended for vape use, highlighting the rapid spread of the pro
Aug.28 by 2FIRSTS.ai
Nova Scotia, Canada: 16% of Residents Vape; Local E-Liquids and Disposable Products in High Demand
Nova Scotia, Canada: 16% of Residents Vape; Local E-Liquids and Disposable Products in High Demand
The latest data show that in 2024, disposable vape sales in Nova Scotia grew by 25%, and about 16% of residents use vaping products—signaling strong demand for tobacco alternatives. The province’s regulatory framework is forcing retailers to accelerate product-line adjustments and compliance upgrades.
Sep.23 by 2FIRSTS.ai
Nepalese Authorities Prosecute E-cigarette Smuggling Ring: Over 310,000 Devices Involved, Facing Fines Exceeding $100 Million
Nepalese Authorities Prosecute E-cigarette Smuggling Ring: Over 310,000 Devices Involved, Facing Fines Exceeding $100 Million
The Department of Revenue Investigation (DRI) of Nepal has filed charges against 12 individuals accused of smuggling more than 310,000 e-cigarettes through fraudulent trade, causing tax losses of around USD 10 million. Prosecutors are seeking fines of nearly NPR 17.5 billion (about USD 100 million) as well as prison sentences. The defendants also face the maximum prison terms under law. The investigation revealed that the group used nearly 100 containers to transport goods and sold the products
Aug.19 by 2FIRSTS.ai
Smoore International's subsidiary, Transcend Biopharma, has its ANDA accepted by the FDA, potentially granting it 180 days of market exclusivity
Smoore International's subsidiary, Transcend Biopharma, has its ANDA accepted by the FDA, potentially granting it 180 days of market exclusivity
Smoore International announced that the U.S. FDA has accepted the Abbreviated New Drug Application (ANDA) for its Breo® Ellipta® 100/25 generic drug, submitted by its wholly-owned subsidiary, Transpire Bio. Transpire Bio stated that if approved, it is expected to receive 180 days of market exclusivity. In the United States, Breo® Ellipta® is already approved for the maintenance treatment of asthma and chronic obstructive pulmonary disease (COPD).
Sep.25 by 2FIRSTS.ai
Australia cracks down on major tobacco smuggling case, involving tax evasion exceeding US$24.21 million
Australia cracks down on major tobacco smuggling case, involving tax evasion exceeding US$24.21 million
Australian police seize tons of illicit tobacco and millions of cigarettes in Victoria's largest illegal tobacco case.
Sep.11 by 2FIRSTS.ai
TSA: E-Cigarettes and Vaping Devices Must Be Carried On, Not Checked
TSA: E-Cigarettes and Vaping Devices Must Be Carried On, Not Checked
The U.S. Transportation Security Administration (TSA) reiterates that e-cigarettes and electronic vaping devices must be placed in carry-on baggage and are strictly prohibited in checked luggage, primarily because lithium batteries pose a fire risk in the cargo hold. Travelers must prevent accidental activation, observe battery capacity limits, and note that e-cigarettes and traditional tobacco are completely prohibited for in-flight use.
Sep.23